Zobrazeno 1 - 5
of 5
pro vyhledávání: '"V. Vl. Yakusevich"'
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 19, Iss 5, Pp 486-494 (2023)
Aim. To present clinical characteristics and assess serious adverse outcomes (death, acute cardiovascular events) in outpatients with atrial fibrillation (AF) in one of the Yaroslavl clinics for 10 years.Material and methods. A total of 212 patients
Externí odkaz:
https://doaj.org/article/89d4ebe9fadf47099d07dddd00f1b8c9
Autor:
M. M. Loukianov, E. Yu. Andreenko, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, E. Yu. Okshina, V. V. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, V. G. Klyashtorny, E. V. Kudryashov, Ju. E. Tatsii, S. A. Boytsov, O. M. Drapkina
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 16, Iss 6, Pp 888-898 (2020)
Aim. To study comorbidity, drug therapy and outcomes in patients with atrial fibrillation (AF) included in the outpatient and hospital RECVASA registries.Material and methods. Patients with AF (n=3169; age 70.9±10.7 years; 43.1% of men) in whom como
Externí odkaz:
https://doaj.org/article/cfdcd982a2af41b792e5349981d3ba70
Autor:
M. M. Loukianov, S. Yu. Martsevich, O. M. Drapkina, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. Y. Andreenko, V. G. Klyashtorny, E. V. Kudryashov, E. Yu. Okshina, M. A. Panagopulu, S. A. Boytsov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 15, Iss 4, Pp 538-545 (2019)
Aim. To evaluate an incidence of oral anticoagulants (OAC) administration during longterm follow-up period in patients with atrial fibrillation (AF) enrolled in outpatient and hospital RECVASA registries.Material and methods. 3169 patients with AF we
Externí odkaz:
https://doaj.org/article/cffb8f5bb8cf4bad9b3036b762be4b08
Autor:
M. M. Loukianov, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, T. A. Gomova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, M. A. Bichurina, L. A. Matskevich, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, A. D. Deev, O. M. Drapkina, s. A. Boytsov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 14, Iss 1, Pp 40-46 (2018)
Am. To study in the RECVASA registers the availability of data about the international normalized ratio (INR) indicator and achievement of its target values in outpatient and hospital practice in patients with atrial fibrillation (AF) receiving antic
Externí odkaz:
https://doaj.org/article/14fbcd52da484660b67660e5a7c353f4
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 7, Pp 120-126 (2015)
Stable angina pectoris is the most prevalent type of ischemic heart disease. In its treatment, the main role play drugs that block adhesion and aggreagation of platelets — antiaggregants. Their role in prevention of cardiovascular complications in
Externí odkaz:
https://doaj.org/article/6c958dd8e3774d27b5271a51cb62e009